نتائج البحث - "Bastian von Tresckow"

1

Reinduction therapy with everolimus in combination with dexamethasone, high‐dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD‐R3i)

المصدر: British Journal of Haematology. 196:606-616

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff0e354fe4bdc404cc0b06b20f948d15Test
https://doi.org/10.1111/bjh.17878Test

2

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

المساهمون: Hematology, CCA - Imaging and biomarkers, CCA - Cancer Treatment and quality of life

المصدر: The Lancet Oncology, 22(2), 223-234. Lancet Publishing Group
Borchmann, P, Plütschow, A, Kobe, C, Greil, R, Meissner, J, Topp, M S, Ostermann, H, Dierlamm, J, Mohm, J, Thiemer, J, Sökler, M, Kerkhoff, A, Ahlborn, M, Halbsguth, T V, Martin, S, Keller, U, Balabanov, S, Pabst, T, Vogelhuber, M, Hüttmann, A, Wilhelm, M, Zijlstra, J M, Moccia, A, Kuhnert, G, Bröckelmann, P J, von Tresckow, B, Fuchs, M, Klimm, B, Rosenwald, A, Eich, H, Baues, C, Marnitz, S, Hallek, M, Diehl, V, Dietlein, M & Engert, A 2021, ' PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial ', The Lancet Oncology, vol. 22, no. 2, pp. 223-234 . https://doi.org/10.1016/S1470-2045Test(20)30601-X
Strahlentherapie Und Onkologie

مصطلحات موضوعية: Male, medicine.medical_treatment, Medizin, Procarbazine, Gastroenterology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, 030212 general & internal medicine, 610 Medicine & health, Etoposide, education.field_of_study, Middle Aged, Combined Modality Therapy, Hodgkin Disease, Dacarbazine, Treatment Outcome, Oncology, Vincristine, 030220 oncology & carcinogenesis, Female, Rituximab, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Population, Vinblastine, Disease-Free Survival, Bleomycin, Young Adult, 03 medical and health sciences, Internal medicine, Mucositis, Humans, education, Cyclophosphamide, Neoplasm Staging, Proportional Hazards Models, Chemotherapy, business.industry, medicine.disease, Regimen, ABVD, Doxorubicin, Positron-Emission Tomography, Prednisone, business, Literatur Kommentiert

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f13d466acfe65ac8d5c77ff231c4382Test
https://doi.org/10.1016/s1470-2045Test(20)30601-x

3

Early Response to First-Line Anti–PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial

المؤلفون: Paul J Bröckelmann, Bastian von Tresckow, Christian Baues, Peter Borchmann, Helen Goergen, Michael Fuchs, Markus Dietlein, Horst Müller, Jasmin Mettler, Andrea Kerkhoff, Ulrich Keller, Andreas Engert, Conrad-Amadeus Voltin, Carsten Kobe, Stephanie Sasse, Lutz van Heek, Karolin Trautmann-Grill, Julia Meissner

المصدر: Clinical Cancer Research. 27:402-407

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Dacarbazine, Medizin, Vinblastine, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Outcome Assessment, Health Care, Humans, Medicine, Doxorubicin, Prospective Studies, Immune Checkpoint Inhibitors, Chemotherapy, business.industry, Middle Aged, medicine.disease, Hodgkin Disease, Survival Analysis, 3. Good health, Lymphoma, Radiation therapy, Nivolumab, 030104 developmental biology, Positron-Emission Tomography, 030220 oncology & carcinogenesis, Concomitant, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb5b1929ac4963afc27a78f6b16b1f73Test
https://doi.org/10.1158/1078-0432.ccr-20-3303Test

4

Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis

المؤلفون: Paul J, Bröckelmann, Horst, Müller, Sarah, Gillessen, Xiaoqin, Yang, Larissa, Koeppel, Veronika, Pilz, Patricia, Marinello, Peter, Kaskel, Monika, Raut, Michael, Fuchs, Peter, Borchmann, Andreas, Engert, Bastian, von Tresckow

المصدر: Leukemia. 36(3)

مصطلحات موضوعية: Adult, Male, Salvage Therapy, Hematopoietic Stem Cell Transplantation, Kaplan-Meier Estimate, Middle Aged, Combined Modality Therapy, Hodgkin Disease, Transplantation, Autologous, Progression-Free Survival, Young Adult, Treatment Outcome, Germany, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Neoplasm Recurrence, Local, Aged

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::06f3a41b5ad58cbc93bf5d183da7f41fTest
https://pubmed.ncbi.nlm.nih.gov/34628472Test

5

Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)

المؤلفون: Peter Borchmann, Richard Greil, Volker Diehl, Josée M. Zijlstra, Jana Markova, Julia Meissner, Sarah Gillessen, Andreas Engert, Max S. Topp, Annette Plütschow, Dennis A. Eichenauer, Bastian von Tresckow, Michael Fuchs, Paul J Bröckelmann

المساهمون: Hematology, CCA - Cancer Treatment and quality of life

المصدر: Gillessen, S, Plütschow, A, Fuchs, M, Markova, J, Greil, R, Topp, M S, Meissner, J, Zijlstra, J M, Eichenauer, D A, Bröckelmann, P J, Diehl, V, Borchmann, P, Engert, A & von Tresckow, B 2021, ' Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14) ', The Lancet Haematology, vol. 8, no. 4, pp. e278-e288 . https://doi.org/10.1016/S2352-3026Test(21)00029-6
The Lancet Haematology, 8(4), e278-e288. Lancet Publishing Group